Medtech Partners

On November 6th, Respira Technology participated in the Medtech Meeting, where we presented the potential of breath-based biomarker detection and discussed the broader applicability of our technology.

The primary focus of Respira is the detection of nitrous oxide (laughing gas). We currently have a working prototype and are progressing rapidly in the development and validation of this technology. At the same time, we are exploring the detection of additional breath biomarkers that may be relevant for the prevention and early detection of diseases.

The Medtech Meeting, hosted by Medtech Partners, provided a valuable opportunity to connect with a broad range of stakeholders from the medtech field. We were pleased to establish new connections and to expand our network with experts and organizations active in medical technology and innovation.